Chargement en cours...
Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
Peginesatide is the newest erythropoietin-stimulating agent (ESA) in the quest for the ideal treatment of anemia in chronic kidney disease (CKD) patients. Reduced frequency of administration along with a possibly lower cost as a result of simpler manufacturing techniques compared with other availabl...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3848525/ https://ncbi.nlm.nih.gov/pubmed/24348017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S34935 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|